Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fatima Chorfa

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The Lancet. Respiratory Medicine|November 1, 2023
Discussions on VT4COVID - Authors' replyJean-Christophe Richard, Muriel Rabilloud, Fatima Chorfa, et al.
The Lancet. Respiratory Medicine|July 15, 2023
Ultra-low tidal volume ventilation for COVID-19-related ARDS in France (VT4COVID): a multicentre, open-label, parallel-group, randomised trialJean-Christophe Richard, Nicolas Terzi, Hodane Yonis, et al.
Epilepsia Open|April 28, 2025
Efficacy of naloxone in reducing hypoxemia and duration of immobility following focal to bilateral tonic-clonic seizuresSylvain Rheims, Fatima Chorfa, Véronique Michel, et al.
The Lancet Regional Health. Europe|August 22, 2024
Diagnostic and prognostic biomarkers in immune checkpoint inhibitor-related encephalitis: a retrospective cohort studyAntonio Farina, Macarena Villagrán-García, Anthony Fourier, et al.
Frontiers in Stroke|January 16, 2026
Regenerative stem cell therapy for stroke in Europe (RESSTORE): a multicenter randomized controlled efficacy clinical trialLoïc Legris, Anaick Moisan, Assia Jaillard, et al.
Lancet (London, England)|August 16, 2025
Spironolactone in patients on chronic haemodialysis at high risk of adverse cardiovascular outcomes (ALCHEMIST): a multicentre, double-blind, randomised, placebo-controlled trial and updated meta-analysisPatrick Rossignol, Faiez Zannad, Ziad Massy, et al.
The Lancet. Neurology|November 24, 2025
Seizure-related biomarkers of sudden unexpected death in epilepsy (SUDEP) in drug-resistant focal epilepsy (REPO<sub>2</sub>MSE): a prospective, multicentre case-control studyPhilippe Ryvlin, Margaux Huot, Luc Valton, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The Lancet. Respiratory Medicine|November 1, 2023
Discussions on VT4COVID - Authors' replyJean-Christophe Richard, Muriel Rabilloud, Fatima Chorfa, et al.
The Lancet. Respiratory Medicine|July 15, 2023
Ultra-low tidal volume ventilation for COVID-19-related ARDS in France (VT4COVID): a multicentre, open-label, parallel-group, randomised trialJean-Christophe Richard, Nicolas Terzi, Hodane Yonis, et al.
Epilepsia Open|April 28, 2025
Efficacy of naloxone in reducing hypoxemia and duration of immobility following focal to bilateral tonic-clonic seizuresSylvain Rheims, Fatima Chorfa, Véronique Michel, et al.
The Lancet Regional Health. Europe|August 22, 2024
Diagnostic and prognostic biomarkers in immune checkpoint inhibitor-related encephalitis: a retrospective cohort studyAntonio Farina, Macarena Villagrán-García, Anthony Fourier, et al.
Frontiers in Stroke|January 16, 2026
Regenerative stem cell therapy for stroke in Europe (RESSTORE): a multicenter randomized controlled efficacy clinical trialLoïc Legris, Anaick Moisan, Assia Jaillard, et al.
Lancet (London, England)|August 16, 2025
Spironolactone in patients on chronic haemodialysis at high risk of adverse cardiovascular outcomes (ALCHEMIST): a multicentre, double-blind, randomised, placebo-controlled trial and updated meta-analysisPatrick Rossignol, Faiez Zannad, Ziad Massy, et al.
The Lancet. Neurology|November 24, 2025
Seizure-related biomarkers of sudden unexpected death in epilepsy (SUDEP) in drug-resistant focal epilepsy (REPO<sub>2</sub>MSE): a prospective, multicentre case-control studyPhilippe Ryvlin, Margaux Huot, Luc Valton, et al.
Pageof 1